Zepteon
Boston, MA, United States zepteon.com
From their website, Nov 2026
Work here? Claim this listing
About
ZEPTEON develops chromatography resins and affinity purification technology for separating antibodies and Fc-fusions by glycoform and subclass. It serves researchers and developers working on monoclonal antibodies, biosimilars, IVIG, and related therapeutics. The company is based in Boston, Massachusetts, and was established in 2012.
Services
Glycap-3A affinity purification resin
Provides a chromatography resin for separating antibodies based on glycoform and subclass, including nonfucosylated and bisected GlcNAc species.
Antibody glycoform separation
Enables separation of antibodies with specific glycoforms to support analysis and development of antibody therapeutics.
Fc-fusion separation
Supports separation of Fc-fusion proteins using its glycoform- and subclass-based affinity technology.
Biosimilars development support
Helps biosimilar developers tune fucose levels and compare structure:function relationships with innovator molecules.
IVIG enrichment and depletion
Enables enrichment or depletion of immune-activating glycoforms or subclasses in plasma-derived intravenous immunoglobulin.
Capabilities
- Assays and studies
- Antibodies · In vivo · Structure:function studies · Receptor binding comparison · In vitro function studies · In vivo function studies
- Therapeutic areas
- Infectious diseases · Cancer · Autoimmunity · Rare diseases
Instruments and platforms
- Chromatography resins
- Affinity purification resin
Modalities and species
- Modalities
- Antibody · mRNA · Cell therapy · Recombinant protein · Biosimilar · LNP / formulation
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Company
- Founded
- 2012
Locations
- Based in
- Boston, MA, United States
- Sites
- Boston, USA
Similar labs
Work here? Claim this listing